YTHDF3-TRIM2-P53轴促进阴道黑色素瘤 (UVM) 的恶性进展
Haoqing Li1, Yamin Chen1, Wenli Chen1
1Clinical College of Ophthamology, Tianjin Medical University, Tianjin 300020, PR China; Tianjin Key Lab of Ophthamology and Vision Science, Tianjin Eye Institute, Tianjin Eye Hospital, Tianjin 300020, PR China; Nankai University Affiliated Tianjin Eye Hospital, Nankai University Optometry and Vision Sicence Insitute, Tianjin 3000020, PR China.
Cellular signalling
|December 14, 2025
概括
高YTHDF3表达通过TRIM2.2.通过降解P53促进皮膜黑色素瘤 (UVM). 沉默TRIM2抑制UVM瘤发生,为这种罕见的癌症提供了潜在的治疗标.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 卵膜黑色素瘤 (UVM) 是成年人中最常见的初级眼内恶性瘤,占所有黑色素瘤的3-5%.
- 了解推动UVM的分子机制对于开发有效的治疗方法至关重要.
研究的目的:
- 为了研究YTHDF3在皮膜黑色素瘤中的作用.
- 在UVM中识别由YTHDF3调节的分子点和途径.
主要方法:
- 在UVM中对YTHDF3表达的差异和生存分析.
- 在体外测试 (CCK8,殖民地形成,Transwell,伤口愈合) 来评估增殖和迁移.
- RIP-qPCR和CoIP用于确认m6A修饰和蛋白质相互作用.
- 动物模型验证YTHDF3的作用和TRIM2淘汰的效果.
主要成果:
- 高YTHDF3表达与UVM的预后不佳相关.
- YTHDF3促进UVM细胞的增殖,入侵和迁移.
- TRIM2是YTHDF3的m6A基质,通过ubiquitination调解P53蛋白降解.
- 在UVM模型中,TRIM2 Knockdown抑制了YTHDF3驱动的瘤发生.
结论:
- 作为YTHDF3的m6A修饰基质,TRIM2通过UVM中的无素-蛋白酶体系统促进P53的降解.
- 针对YTHDF3-TRIM2-P53轴,特别是通过沉默TRIM2,可以减少UVM的瘤效应.
相关概念视频
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
The Intrinsic Apoptotic Pathway
8.2K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.2K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K


